全文获取类型
收费全文 | 1600篇 |
免费 | 132篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 69篇 |
妇产科学 | 52篇 |
基础医学 | 190篇 |
口腔科学 | 21篇 |
临床医学 | 195篇 |
内科学 | 340篇 |
皮肤病学 | 57篇 |
神经病学 | 77篇 |
特种医学 | 158篇 |
外科学 | 128篇 |
综合类 | 47篇 |
预防医学 | 169篇 |
眼科学 | 19篇 |
药学 | 107篇 |
肿瘤学 | 80篇 |
出版年
2023年 | 10篇 |
2022年 | 11篇 |
2021年 | 39篇 |
2020年 | 10篇 |
2019年 | 27篇 |
2018年 | 36篇 |
2017年 | 28篇 |
2016年 | 24篇 |
2015年 | 31篇 |
2014年 | 34篇 |
2013年 | 68篇 |
2012年 | 52篇 |
2011年 | 49篇 |
2010年 | 39篇 |
2009年 | 55篇 |
2008年 | 55篇 |
2007年 | 56篇 |
2006年 | 44篇 |
2005年 | 58篇 |
2004年 | 55篇 |
2003年 | 55篇 |
2002年 | 48篇 |
2001年 | 42篇 |
2000年 | 44篇 |
1999年 | 45篇 |
1998年 | 49篇 |
1997年 | 38篇 |
1996年 | 47篇 |
1995年 | 31篇 |
1994年 | 35篇 |
1993年 | 36篇 |
1992年 | 42篇 |
1991年 | 30篇 |
1990年 | 16篇 |
1989年 | 25篇 |
1988年 | 33篇 |
1987年 | 28篇 |
1986年 | 31篇 |
1985年 | 31篇 |
1984年 | 24篇 |
1983年 | 21篇 |
1982年 | 20篇 |
1981年 | 13篇 |
1979年 | 12篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1976年 | 11篇 |
1975年 | 15篇 |
1969年 | 14篇 |
1968年 | 14篇 |
排序方式: 共有1733条查询结果,搜索用时 31 毫秒
1.
2.
Liver hemangioma: US-guided 18-gauge core-needle biopsy 总被引:6,自引:0,他引:6
3.
Electrophysiologic effects of d-sotalol in humans 总被引:1,自引:0,他引:1
J M McComb B McGovern J B McGowan J N Ruskin H Garan 《Journal of the American College of Cardiology》1987,10(1):211-217
Sotalol is a beta-adrenergic blocking agent that prolongs the duration of the cardiac action potential in humans, without affecting the upstroke velocity of depolarization. The dextrorotatory isomer, d-sotalol, retains these class III effects, but has little beta-blocking activity in vitro. d-Sotalol has not been studied extensively in humans. The electrocardiographic (ECG) and electrophysiologic effects of d- and d,l-sotalol were therefore assessed in a prospective randomized study of 20 patients. Each patient received either d-sotalol (1, 1.5 or 2 mg/kg body weight) or d,l-sotalol (1 mg/kg) by intravenous infusion. The QT and QTc intervals were prolonged and refractoriness increased in the atrium, atrioventricular (AV) node, His-Purkinje system and right ventricle after both d- and d,l-sotalol. After d-sotalol, the increases in both QT and QTc intervals and in atrial and ventricular effective refractory periods were dose dependent. Highly significant linear correlation was demonstrated between the plasma sotalol level and the change in QT (r = 0.86, p = 0.001) and QTc intervals (r = 0.79, p = 0.002), and between the plasma sotalol level and the effective refractory period of the right atrium (r = 0.75, p = 0.005) and ventricle (r = 0.70, p = 0.025). This study confirms that d-sotalol has effects consistent with class III properties. It demonstrates these effects in humans, and suggests that d-sotalol may prove to be a useful antiarrhythmic agent. 相似文献
4.
Cardiovascular observation unit: meeting the expanding needs of an integrated cardiovascular center.
K J McGovern 《The Journal of cardiovascular management》1998,9(1):15-18
By developing a flexible unit that can easily manage a diverse cardiac population, the Cardiovascular Center as well as the Medical Center reduced expenses and increased operational efficiency. In addition to the economic and operational benefits, patients and their families have been impacted favorably by the unit's design and operation. As cardiovascular administrators search for ways to reduce expenses and increase operational efficiencies, they should consider the positive effects of a unit similar to our CVOU within their institution. 相似文献
5.
6.
BACKGROUND: There are obvious advantages to increasing donor retention. However, for reasons of blood safety, certain donors may, in fact, be more desirable to retain than others. “Safe” donors are defined as those who provided a blood donation that was negative on all laboratory screening tests and who subsequently reported no behavioral risks in response to an anonymous survey. This study identifies the most important factors affecting the intention of “safe” donors to provide another donation. STUDY DESIGN AND METHODS: An anonymous survey asking about donation history, sexual history, injecting drug use, and recent donation experience was mailed to 50,162 randomly selected allogeneic donors (including directed donors) who gave blood from April through July or from October through December 1993 at one of the five United States blood centers participating in the Retrovirus Epidemiology Donor Study. Before mailing, questionnaires were coded to designate donors with nonreactive laboratory screening tests at their most recent donation. RESULTS: A total of 34,726 donors (69%) responded, with substantially higher response among repeat donors. According to reported intentions only, the vast majority of “safe” donors indicated a high likelihood of donating again within the next 12 months. Only 3.4 percent reported a low likelihood of donating again. A comparison of those likely to return and those unlikely to return reveals significant differences in demographics and in ratings of the donation experience. A higher proportion of those unlikely to return were first-time donors, minority-group donors, and donors with less education. The highest projected loss among “safe” donors was seen for those who gave a fair to poor assessment of their treatment by blood center staff or of their physical well-being during or after donating. CONCLUSION: These data suggest that efforts to improve donors' perceptions of their donation experience, as well as attention to the physical effects of blood donation, may aid in the retention of both repeat and first-time donors. 相似文献
7.
From 1958 through 1985, a total of 113 consecutive patients had completion pneumonectomy (CP). Indications for pulmonary resection resulting in CP were lung cancer (LC) in 64 patients, pulmonary metastases (PM) in 20, and benign lung disease (BLD) in 29. Operative mortality was 12.4% (14 deaths) but varied according to the indication for CP. Mortality was 9.4% for LC, 0% for PM, and 27.6% for BLD. Forty-three patients (38.1%) had major complications (26 of 64 with LC, 40.6%; 1 of 20 with PM, 5.0%; and 16 of 29 with BLD, 55.2%). Five-year actuarial survival for patients with LC was 26.4% but varied according to stage. Five-year survival for patients with PM was 40.8% and with BLD was 27.2%. We conclude that CP for BLD carries marked operative mortality and morbidity, usually due to intense reaction around hilar structures and concurrent active infection or fistula. In contrast, CP for LC and PM can be performed with low mortality, acceptable morbidity, and gratifying long-term survival. 相似文献
8.
Brian A. McGovern M.D. Hasan Garan M.D. Jeremy N. Buskin M.D. 《Current problems in cardiology》1988,13(12):790-859
Within the past 20 years, our knowledge concerning the epidemiology, natural history, and treatment of VT has expanded greatly. A variety of effective pharmacologic, surgical and electrical therapies for VT are now available to the clinician. Patients who present with ventricular, tachyarrhythmias should undergo a comprehensive medical evaluation directed at identifying and treating such factors as ischemia, congestive heart failure, valvular heart disease, sensitivity to cardioactive drugs, and metabolic derangements. Many patients who present with asymptomatic ventricular arrhythmias do not require specific antiarrhythmic drug therapy. However, certain patients who have already suffered a life-threatening arrhythmia or who are at high risk for such arrhythmia should be vigorously treated with specific antiarrhythmic therapy guided for that individual patient. The efficacy of any antiarrhythmic treatment should be assessed by ECG monitoring, exercise testing, and/or electrophysiologic study. In the near future, potentially revolutionary new electrical therapies for ventricular tachyarrhythmias will be evaluated. It is to be hoped that these devices used in combination with pharmacologic and surgical therapies may dramatically reduce the incidence of sudden cardiac death in high-risk patients. 相似文献
9.
Five chemical repellents, a controlled-release repellent formulation, Avon Skin-So-Soft bath oil and permethrin-impregnated clothing fabric were assayed for personal protection against bites of Aedes albopictus. On skin the chemical repellents provided significant (P = 0.05) protection from biting; however, Ae. albopictus was more sensitive to the repellents than the standard, Ae. aegypti. Two experimental repellents provided 6-7 h protection from bites, 25% deet in ethanol provided greater than 8 h protection, a controlled-release formulation containing 35% deet provided greater than 10 h protection, and the Avon product provided 0.64 h protection from bites. Permethrin-treated fabric provided complete protection from mosquito bites through 0-5 washings. Repellent products containing greater than or equal to 12% deet should provide satisfactory protection against Ae. albopictus; the use of permethrin-impregnated clothing should provide additional protection. 相似文献
10.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; von dem Borne AE; van der Schoot CE 《Blood》1995,86(2):692-702
Crosslineage T-cell receptor delta (TCR delta) rearrangements are widely used as tumor markers for the follow up of minimal residual disease in childhood B-precursor acute lymphoblastic leukemia (ALL) by polymerase chain reaction (PCR). The major drawback of this approach is the risk of false-negative results due to clonal evolution. We investigated the stability of V delta 2D delta 3 rearrangements in a group of 56 childhood B-precursor ALL patients by PCR and Southern blot analysis. At the PCR level, V delta 2D delta 3-to-J alpha rearranged subclones (one pathway for secondary TCR delta recombination) were demonstrated in 85.2% of V delta 2D delta 3-positive patients tested, which showed that small subclones are present in the large majority of patients despite apparently monoclonal TCR delta Southern blot patterns. Sequence analysis of V delta 2D delta 3J alpha rearrangements showed a biased J alpha gene usage, with HAPO5 and J alpha F in 26 of 32 and 6 of 32 clones, respectively. Comparison of V delta 2D delta 3 rearrangement status between diagnosis and first relapse showed differences in seven of eight patients studied. In contrast, from first relapse onward, no clonal changes were observed in six patients studied. To investigate the occurrence of crosslineage TCR delta rearrangements in normal B and T cells, fluorescence-activated cell sorter-sorted peripheral blood CD19+/CD3- and CD19-/CD3+ cell populations from three healthy donors were analyzed. V delta 2D delta 3 rearrangements were detected at low frequencies in both B and T cells, which suggests that V delta 2-to-D delta 3 joining also occurs during normal B-cell differentiation. A model for crosslineage TCR delta rearrangements in B-precursor ALL is deduced that explains the observed clonal changes between diagnosis and relapse and is compatible with multistep leukemogenesis of B-precursor ALL. 相似文献